Clinical Trial: Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Human Immunodeficiency Virus
Study Type: INTERVENTIONAL
Official Title: Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya
Brief Summary:
The objective of this randomized, placebo-controlled trial is to evaluate whether intravaginal artesunate pessaries (vaginal inserts) can be used as adjuvant therapy following thermal ablation to improve Human papillomavirus (HPV) treatment outcomes in Women Living with Human Immunodeficiency Virus (WLWH).The study will evaluate whether women who use artesunate will have higher HPV clearance at 6 months, compared to those who used a placebo.The study will also assess the safety, adherence, and acceptability of…
Read more